With that becoming said, with no human trials there's no way to truly assess the amount of YK11 can inhibit Myostatin in individuals (if in any way), and when there is a dosage which could equate to exactly the same degree of Myostatin inhibition that a genetic anomaly which has a gene mutation has.Similarly, “bro science” or peer consensus nee